Performance funds/ETFs
Growth in fund currency
Available documents (NL)
Available documents (EN)
Available documents for this product 
Quote
Quote
€217,50
Quote date
18-05-2026
Performance in EUR
Date
18-05-2026
This year
-3,06%
1 week
0,61%
1 month
-4,14%
3 months
-9,67%
6 months
-0,71%
1 year
6,02%
3 years (annualised)
1,62%
5 years (annualised)
5,39%
Since start (annualised)
7,46%
Indicators
Standard deviation (3yr)
15,00%
Share ratio (3yr)
0,04
Beta (3yr)
1,03
Alpha (3yr)
0,43
Tracking error (3yr)
7,12
Top 10 holdings (30-04-2026)
Roche Holding AG Ordinary Shares new
18,92 %
AstraZeneca PLC
18,27 %
Novartis AG Registered Shares
18,05 %
Novo Nordisk AS Class B
9,10 %
Sanofi SA
6,80 %
Essilorluxottica
4,21 %
argenx SE
3,21 %
Lonza Group Ltd
2,85 %
Haleon PLC
2,72 %
Galderma Group AG Registered Shares
2,55 %
Fees
Entry fee
->Tarievenkaart / Cost information sheet
Exit charges
->Tarievenkaart / Cost information sheet
Estimated ongoing charges
0,17%
Dividend
Dividend paying
No
Characteristic
Asset Manager
Xtrackers
Asset class
Equities
Investment category
Equities - Healthcare
Active/Passive
Passief etf
Fund code
241286
Fund code fractional orders
-
Fund manager name
Not Disclosed
ISIN
LU0292103222
Sustainable Classification
Art. 8, ESG integration
Sustainability Rating
Domicile
Luxembourg
Currency
EUR
Fund size (mio)
262,17 (15-05-2026)
Cut-off time
-
Execution date
niet van toepassing: directe verhandeling op de beurs
Inception date
26-06-2007
Benchmark
MSCI Euro HlCr ESG Scrn 20-35 Sel NR EUR
Minimum investment amount
-
Assortiment
Self Directed Investing Plus, Investment advice